Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Diabetes & Metabolism Journal|December 23, 2017
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes AssociationHyun Jin Kim, Seok O Park, Seung Hyun Ko, et al.
Diabetologia|May 7, 2025
Time in tight range and time in range for predicting the achievement of typical glucose management indicator and HbA<sub>1c</sub> targetsSeohyun Kim, Sang Ho Park, Jin A Lee, et al.
Head & Neck|December 24, 2009
Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457)Ji In Lee, Ji Young Kim, Joon Young Choi, et al.
Diabetes & Metabolism Journal|November 1, 2017
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes AssociationSeung Hyun Ko, Kyu Yeon Hur, Sang Youl Rhee, et al.
Diabetes & Metabolism Journal|November 1, 2017
Monotherapy in Patients with Type 2 Diabetes MellitusSang Youl Rhee, Hyun Jin Kim, Seung Hyun Ko, et al.
Diabetes & Metabolism Journal|November 1, 2017
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes MellitusMin Kyong Moon, Kyu Yeon Hur, Seung Hyun Ko, et al.
European Journal of Endocrinology|July 28, 2007
The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatmentSoo-Kyung Kim, Kyu-Yeon Hur, Hae-Jin Kim, et al.
The American Journal of Clinical Nutrition|March 31, 2004
Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseasesSoo Kyung Kim, Hae Jin Kim, Kyu Yeon Hur, et al.
Clinical Endocrinology|September 21, 2006
The long-term effects of rosiglitazone on serum lipid concentrations and body weightWan Sub Shim, Mi Young Do, Soo Kyung Kim, et al.
The Korean Journal of Internal Medicine|July 1, 2011
Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves' diseaseJi In Lee, Hye Won Jang, Soo Kyoung Kim, et al.
Pageof 19